Tait T, le Gallez P, Astbury C, Bird H
Clin Rheumatol. 1994; 13(1):75-9.
PMID: 8187448
DOI: 10.1007/BF02229869.
Dixon J, Bird H, Sitton N, Pickup M, Leatham P, WRIGHT V
Agents Actions. 1983; 13(4):373-9.
PMID: 6613752
DOI: 10.1007/BF01971492.
Dixon J, Bird H, Surrall K, Sitton N, WRIGHT V
Clin Rheumatol. 1984; 3(4):451-7.
PMID: 6525784
DOI: 10.1007/BF02031267.
McKenna F, Martin M, Bird H, WRIGHT V
Br Med J (Clin Res Ed). 1983; 287(6401):1299.
PMID: 6416376
PMC: 1549681.
DOI: 10.1136/bmj.287.6401.1299.
Bird H
Clin Rheumatol. 1985; 4(2):121-3.
PMID: 4006383
DOI: 10.1007/BF02032281.
Short-term clinical trials of anti-rheumatoid drugs--an opinion.
Dixon J
Agents Actions. 1987; 21(1-2):89-92.
PMID: 3630860
DOI: 10.1007/BF01974927.
Co-trimoxazole in rheumatoid arthritis: a comparison with sulphapyridine.
Astbury C, Hill J, Bird H
Ann Rheum Dis. 1988; 47(4):323-7.
PMID: 3284488
PMC: 1003514.
DOI: 10.1136/ard.47.4.323.
What happens to patients with rheumatoid arthritis? The long-term outcome of treatment.
Spector T, Scott D
Clin Rheumatol. 1988; 7(3):315-30.
PMID: 3147831
DOI: 10.1007/BF02239187.
A comparison of prednisolone with azathioprine and prednisolone with intramuscular gold in rheumatoid arthritis.
Hantzschel H, Otto W, Arnold S, Seidel W, Kruger W, Winiecki P
Clin Rheumatol. 1988; 7(2):181-7.
PMID: 3138060
DOI: 10.1007/BF02204452.
A clinical and biochemical assessment of etidronate disodium in patients with active rheumatoid arthritis.
Bird H, Hill J, Sitton N, Dixon J, WRIGHT V
Clin Rheumatol. 1988; 7(1):91-4.
PMID: 3136966
DOI: 10.1007/BF02284063.
Treatment of severe rheumatoid arthritis.
WRIGHT V
Br Med J (Clin Res Ed). 1986; 292(6518):431-2.
PMID: 3081111
PMC: 1339418.
DOI: 10.1136/bmj.292.6518.431.
A clinical and biochemical evaluation of etretinate in rheumatoid arthritis.
Bird H, Hill J, Sitton N, Dixon J, WRIGHT V
Rheumatol Int. 1988; 8(2):55-9.
PMID: 3041545
DOI: 10.1007/BF00271835.
The abnormal cytotoxic T cell response to Epstein-Barr virus in rheumatoid arthritis is correlated with disease activity and occurs in other arthropathies.
Gaston J, Rickinson A, Yao Q, Epstein M
Ann Rheum Dis. 1986; 45(11):932-6.
PMID: 2878645
PMC: 1002022.
DOI: 10.1136/ard.45.11.932.
5-Aminosalicylic acid or sulphapyridine. Which is the active moiety of sulphasalazine in rheumatoid arthritis?.
Taggart A, Neumann V, Hill J, Astbury C, le Gallez P, Dixon J
Drugs. 1986; 32 Suppl 1:27-34.
PMID: 2877851
DOI: 10.2165/00003495-198600321-00006.
Which component of sulphasalazine is active in rheumatoid arthritis?.
Pullar T, Hunter J, Capell H
Br Med J (Clin Res Ed). 1985; 290(6481):1535-8.
PMID: 2860942
PMC: 1415752.
DOI: 10.1136/bmj.290.6481.1535.
Disease modifying drugs for rheumatoid arthritis: yesterday's treatment today or today's treatment tomorrow?.
Pullar T
Br J Clin Pharmacol. 1990; 30(4):501-10.
PMID: 2291864
PMC: 1368239.
DOI: 10.1111/j.1365-2125.1990.tb03807.x.
